Casey Means Faces Scrutiny During Senate Hearing for Surgeon General Nomination
February 25, 2026
President Donald Trump’s nominee for U.S. Surgeon General, Dr. Casey Means, faced rigorous questioning from the Senate Health, Education, Labor and Pensions (HELP) committee on Wednesday, February 25, 2026. The hearing, initially postponed due to the birth of Dr. Means’ child in October, focused on her stance on vaccination, potential conflicts of interest stemming from her work as a wellness influencer and concerns regarding the health effects of AI data centers.
Vaccination Stance Under Examination
A central point of contention during the hearing was Dr. Means’ previous statements regarding vaccination, particularly the hepatitis B vaccine. Senator Angela Alsobrooks (D-MD) questioned Dr. Means about a social media post where she referred to vaccinating against hepatitis B at birth as “a crime.”
Dr. Means responded by stating her support for vaccines and their role in public health. She emphasized the importance of a “nuanced conversation” between families and their doctors regarding specific vaccines, acknowledging varying levels of risk. However, Committee Chairman Senator Bill Cassidy (R-LA) pressed her on whether she advocated for a more formal informed consent process, similar to that used for surgical procedures. Dr. Means clarified that she aimed to encourage open and unhurried discussions between doctors and parents, free from shame or judgment.
Concerns Over Wellness Influencer Activities and Conflicts of Interest
Senators also raised concerns about Dr. Means’ work as a wellness influencer and potential conflicts of interest. Senator Alsobrooks pointed out that Dr. Means had criticized pharmaceutical advertising even as simultaneously accepting sponsorships from various companies, including one that faced scrutiny from the Food and Drug Administration (FDA) after causing widespread illness.
Dr. Means assured the committee that she takes conflicts of interest “very seriously” and has been working with the Office of Government Ethics to address any potential issues. She committed to divesting from any conflicting interests if confirmed as Surgeon General.
AI and Environmental Health Concerns
Senator Josh Hawley (R-MO) inquired about the potential health effects of AI data centers, particularly in rural and working-class communities. He cited reports of residents experiencing migraines, vertigo, and sleep disruption near these facilities.
Dr. Means acknowledged the concerns and expressed interest in researching the impact of environmental exposures on health, stating that this issue would fall within her purview if confirmed.
She also addressed the tragic case of a 16-year-ancient who died by suicide after allegedly being encouraged by an AI chatbot, expressing her commitment to protecting children’s health and safety.
Next Steps
The Senate HELP committee will now vote on whether to advance Dr. Means’ nomination to the full Senate for a confirmation vote. Republicans hold a one-seat majority on the committee and control the Senate. Senators have until February 26, 2026, to submit additional questions for the record.
Expert Analysis
Arthur L. Caplan, PhD, a professor and founding head of the division of medical ethics at NYU Grossman School of Medicine, expressed reservations about Dr. Means’ candidacy. He noted her lack of recent clinical practice and her involvement in the “fraudulent wellness industry.” Caplan emphasized the importance of a Surgeon General who commands public trust through experience and adherence to evidence-based medicine.
He specifically voiced concern over Dr. Means’ responses regarding the hepatitis B vaccine, stating that a strong endorsement of vaccination is crucial for the role.
Sources: